HomeFilePharmacology

Pharmacology

View Category

Coronary disease

Rapid Drop of Antibodies in Mild COVID-19 patients

A fast drop in COVID-19 antibodies in mild patients triggers the alarm for protection against the new...
solaci -
Learn More
Other

Peripheral Artery Disease: Underestimated and Undertreated

Compared against coronary artery disease (CAD) or cerebrovascular disease patients, peripheral artery disease (PAD) patients have lower...
solaci -
Learn More
Coronary disease

Vasculitis, Thrombosis and Angiogenesis: Covid-19´s Unique Patters

In this small, yet interesting series, we observe angiogenesis could differentiate pulmonary physiopathology by Covid-19 vs. from...
solaci -
Learn More
Acute coronary syndromes

EuroPCR 2020 | FABOLUS FASTER: In the Quest for the Fastest, Most Potent Platelet Inhibition

This small study tested the pharmacodynamic effects of several antiplatelet agents. It concluded that tirofiban (Aggrastat) provides...
solaci -
Learn More
Chronic Ischemic cardiopathy

Olive Oil and Cardiovascular Risk: The Higher the Consumption, the Lower the Risk?

High olive oil intake was associated with lower risk of coronary heart disease and cardiovascular disease in...
solaci -
Learn More
Antiplatelet

The FDA Approves Ticagrelor for Primary Prevention in High Risk Patients

The FDA has approved the indication of ticagrelor as primary prevention in high risk CAD patients with...
solaci -
Learn More
Acute coronary syndromes

Optimal Intervention Timing for NSTEMI with No Antiaggregant Pre-Treatment

Patients undergoing non-ST elevation MI (NSTEMI) who are not pre-treated with P2Y12 receptor inhibitors will benefit from...
solaci -
Learn More
Coronary disease

Estimating the Risk of Infection for Healthcare Personnel

Roughly one out of every 100 healthcare workers at hospitals receiving COVID-19 patients become infected. Statistics are not...
solaci -
Learn More